Observational studyAnnals of clinical microbiology and antimicrobials2018

Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.

Hiroki Tanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.